Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pietro Invernizzi

Showing results (271-280 of 420) with videos related to

Pageof 42
Sort By:
Oncotarget|June 25, 2019
Free episomal and integrated HBV DNA in HBsAg-negative patients with intrahepatic cholangiocarcinomaTeresa Pollicino, Cristina Musolino, Carlo Saitta, et al.
Hepatology (Baltimore, Md.)|September 8, 2011
Immunoglobulin M levels inversely correlate with CD40 ligand promoter methylation in patients with primary biliary cirrhosisAna Lleo, Jieyue Liao, Pietro Invernizzi, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 19, 2010
A short version of a HRQoL questionnaire for Italian and Japanese patients with Primary Biliary CirrhosisLorenzo Montali, Atsushi Tanaka, Paolo Riva, et al.
Cancer Research|November 18, 2008
Serotonin metabolism is dysregulated in cholangiocarcinoma, which has implications for tumor growthGianfranco Alpini, Pietro Invernizzi, Eugenio Gaudio, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 12, 2022
Primary biliary cholangitis: perception and expectation of illnessAnnarosa Floreani, Michela Scaffidi, Barbara Coco, et al.
Journal of Autoimmunity|May 10, 2005
Genetic polymorphisms of toll-like receptor 9 influence the immune response to CpG and contribute to hyper-IgM in primary biliary cirrhosisKentaro Kikuchi, Zhe-Xiong Lian, Yasuhiko Kimura, et al.
Hepatology (Baltimore, Md.)|November 13, 2008
Human leukocyte antigen polymorphisms in Italian primary biliary cirrhosis: a multicenter study of 664 patients and 1992 healthy controlsPietro Invernizzi, Carlo Selmi, Francesca Poli, et al.
Cellular & Molecular Immunology|February 6, 2018
Comprehensive review of autoantibodies in patients with hyper-IgM syndromeMohamed-Ridha Barbouche, Qubo Chen, Marco Carbone, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 22, 2017
Prolonged darkness reduces liver fibrosis in a mouse model of primary sclerosing cholangitis by miR-200b down-regulationNan Wu, Fanyin Meng, Tianhao Zhou, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 28, 2026
IGFBP4 is a Metric for Primary Biliary Cholangitis and Attenuates Biliary Epithelial Cell InjuryXing Zhou, Shuyu Shao, Danning Yang, et al.
Pageof 42

Showing results (271-280 of 420) with videos related to

Sort By:
Pageof 42
Oncotarget|June 25, 2019
Free episomal and integrated HBV DNA in HBsAg-negative patients with intrahepatic cholangiocarcinomaTeresa Pollicino, Cristina Musolino, Carlo Saitta, et al.
Hepatology (Baltimore, Md.)|September 8, 2011
Immunoglobulin M levels inversely correlate with CD40 ligand promoter methylation in patients with primary biliary cirrhosisAna Lleo, Jieyue Liao, Pietro Invernizzi, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 19, 2010
A short version of a HRQoL questionnaire for Italian and Japanese patients with Primary Biliary CirrhosisLorenzo Montali, Atsushi Tanaka, Paolo Riva, et al.
Cancer Research|November 18, 2008
Serotonin metabolism is dysregulated in cholangiocarcinoma, which has implications for tumor growthGianfranco Alpini, Pietro Invernizzi, Eugenio Gaudio, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 12, 2022
Primary biliary cholangitis: perception and expectation of illnessAnnarosa Floreani, Michela Scaffidi, Barbara Coco, et al.
Journal of Autoimmunity|May 10, 2005
Genetic polymorphisms of toll-like receptor 9 influence the immune response to CpG and contribute to hyper-IgM in primary biliary cirrhosisKentaro Kikuchi, Zhe-Xiong Lian, Yasuhiko Kimura, et al.
Hepatology (Baltimore, Md.)|November 13, 2008
Human leukocyte antigen polymorphisms in Italian primary biliary cirrhosis: a multicenter study of 664 patients and 1992 healthy controlsPietro Invernizzi, Carlo Selmi, Francesca Poli, et al.
Cellular & Molecular Immunology|February 6, 2018
Comprehensive review of autoantibodies in patients with hyper-IgM syndromeMohamed-Ridha Barbouche, Qubo Chen, Marco Carbone, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 22, 2017
Prolonged darkness reduces liver fibrosis in a mouse model of primary sclerosing cholangitis by miR-200b down-regulationNan Wu, Fanyin Meng, Tianhao Zhou, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 28, 2026
IGFBP4 is a Metric for Primary Biliary Cholangitis and Attenuates Biliary Epithelial Cell InjuryXing Zhou, Shuyu Shao, Danning Yang, et al.
Pageof 42